- It's on the label. Both Wegovy and Zepbound list acute gallbladder disease (gallstones and gallbladder inflammation) among their warnings.
- Uncommon but real: in adult trials, gallstones were reported in 1.6% of Wegovy patients vs 0.7% on placebo, and in 1.1% of Zepbound patients vs 1% on placebo.
- Rapid weight loss raises gallstone risk, but the Wegovy label notes the excess risk persisted even after accounting for weight loss.
- Know the pattern: pain in the upper right or upper middle abdomen, often after meals, that builds and lasts, is different from routine GLP-1 queasiness.
- Fever, yellow skin or eyes, or severe pain that spreads to the back means same-day medical care.
Men starting semaglutide or tirzepatide are usually warned about nausea, diarrhea and constipation. Fewer are told clearly about the gallbladder. That's a problem, because early gallbladder trouble can feel like "just the GLP-1" until it becomes an emergency. This guide lays out what the drug labels say, what symptoms to watch for, and how to tell the difference between a rough week and a reason to get checked.
Why GLP-1s and the gallbladder are linked
Your gallbladder stores bile, a digestive fluid made by the liver, and squeezes it into the intestine when you eat fat. Gallstones form when substances in bile, mostly cholesterol, harden into stones. Rapid weight loss is a long-recognized risk factor for gallstones regardless of how the weight comes off, and eating very little fat for long stretches means the gallbladder empties less often.
GLP-1 drugs add a layer: the Wegovy label states that while substantial or rapid weight loss can increase the risk of gallstones, the rate of acute gallbladder disease was greater with Wegovy than with placebo even after accounting for the degree of weight loss. In other words, the drug itself may contribute, not just the speed of weight loss.
What the labels report
| Event (adult trials) | Wegovy | Placebo | Zepbound | Placebo |
|---|---|---|---|---|
| Gallstones (cholelithiasis) | 1.6% | 0.7% | 1.1% | 1% |
| Gallbladder inflammation (cholecystitis) | 0.6% | 0.2% | 0.7% | 0.2% |
| Gallbladder removal (cholecystectomy) | — | — | 0.2% | 0% |
Figures from each product's prescribing information and are not directly comparable across drugs, because they come from different trials and populations. A dash means the figure was not reported in the label sections we reviewed.
Put plainly: most men on a GLP-1 will never have a gallbladder problem. But across the very large number of men now taking these drugs, a small percentage still adds up to a lot of gallbladders, and it's worth knowing the signs.
Gallbladder warning signs
A gallbladder attack (biliary colic) usually happens when a stone temporarily blocks bile flow. Typical features include:
- Pain in the upper right abdomen, under the ribs, or in the upper middle abdomen just below the breastbone.
- Pain that builds and stays — steady for 30 minutes to several hours rather than coming in quick waves.
- Pain that may spread to the right shoulder or between the shoulder blades.
- Timing after meals, especially larger or fattier ones, often in the evening or at night.
- Nausea or vomiting with the pain.
When a blockage persists, it can lead to inflammation or infection of the gallbladder, or a stone can block the bile duct or the pancreatic duct. Those complications are more serious and more urgent.
- Abdominal pain so intense you can't sit still or get comfortable, or pain lasting more than a few hours.
- Fever or chills along with abdominal pain.
- Yellowing of the skin or the whites of your eyes (jaundice).
- Dark, tea-colored urine or pale, clay-colored stools.
- Severe, persistent pain in the upper abdomen that radiates to your back, with or without vomiting (possible pancreatitis).
Don't forget the pancreas
Acute pancreatitis is a separate warning on GLP-1 labels. The Wegovy safety information describes the signs as persistent severe abdominal pain, sometimes radiating to the back, which may or may not come with vomiting, and says the drug should be stopped if pancreatitis is suspected. Gallstones are themselves one of the most common causes of pancreatitis, which is another reason not to ignore biliary symptoms. Heavy drinking is the other major cause, so alcohol on a GLP-1 deserves extra caution (see our GLP-1 and alcohol guide).
Normal GLP-1 queasiness vs a red flag
| Feature | Typical GLP-1 GI side effect | Possible gallbladder/pancreas problem |
|---|---|---|
| Main feeling | Queasy, full, bloated | Real pain, often steady and intense |
| Location | Vague, whole stomach | Upper right or upper middle abdomen; may spread to back or right shoulder |
| Timing | Days after an injection or dose increase; eases over days to weeks | Episodes after meals or at night; may recur or worsen |
| Other signs | Burping, mild nausea, constipation or diarrhea | Fever, jaundice, dark urine, pale stools, persistent vomiting |
| What to do | Smaller meals, hydrate, tell your prescriber at check-in | Contact a clinician the same day; emergency care for severe signs |
Who may be at higher risk
Your prescriber should ask about these before you start:
- A history of gallstones or gallbladder attacks.
- Previous pancreatitis.
- Very rapid weight loss, or very low-calorie, very low-fat eating patterns.
- Diabetes, older age, and a family history of gallstones, which are general gallstone risk factors.
Having had your gallbladder removed doesn't automatically rule out a GLP-1, but it's information your clinician needs. Be honest on the intake, even if it slows approval. Our GLP-1 provider safety checklist explains what a thorough intake should cover.
Lowering your risk while you lose weight
- Don't crash diet on top of the drug. The medication already lowers appetite; extreme restriction adds risk without adding much benefit.
- Keep some healthy fat in meals. Regular, moderate fat intake keeps the gallbladder emptying.
- Follow the planned dose schedule rather than rushing to the top dose.
- Stay hydrated and limit alcohol.
- Report pain early. An ultrasound is a simple, noninvasive test, and the Wegovy label says gallbladder studies and follow-up are indicated if gallstones are suspected.
For the broader picture of what's normal on these medications, read Men's GLP-1 Side Effects: What to Actually Expect.
Choosing a program that takes this seriously
A good GLP-1 program asks about gallbladder and pancreas history up front, explains these warnings, and gives you a way to reach a clinician when something feels wrong. If you're comparing programs, our weight-loss hub lists the ones we cover.
Frequently asked questions
Do GLP-1s cause gallstones?
They're associated with a higher rate of gallstones and gallbladder inflammation than placebo. In adult Wegovy trials, gallstones were reported in 1.6% of patients vs 0.7% on placebo; for Zepbound, 1.1% vs 1%. Rapid weight loss contributes, but the Wegovy label notes the excess risk persisted after accounting for weight loss.
Where is gallbladder pain felt?
Usually in the upper right abdomen under the ribs or the upper middle abdomen, sometimes spreading to the right shoulder or back. It tends to be steady and last from about half an hour to several hours, often after meals.
Should I stop my GLP-1 if I have gallbladder pain?
Contact your prescriber or seek care promptly; don't simply wait it out. The Wegovy label says gallbladder studies and clinical follow-up are indicated if gallstones are suspected, and that the drug should be stopped if pancreatitis is suspected.
Can I take a GLP-1 if my gallbladder was removed?
Often, yes, but it depends on your overall history, including any past pancreatitis. Tell your prescriber about the surgery during your intake.
How is a gallbladder problem diagnosed?
Usually with a physical exam, blood tests and an abdominal ultrasound. Your clinician decides which tests you need based on your symptoms.
Sources & references
- Novo Nordisk. Wegovy Important Safety Information: acute gallbladder disease and acute pancreatitis. novocare.com
- Zepbound (tirzepatide) prescribing information, adverse reactions section (gallbladder and pancreatitis incidence). medlibrary.org
- Wegovy (semaglutide) prescribing information, adverse reactions and patient counseling. drugcentral.org